A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer
Clinical trial NCT00717340 · COMPLETED
Trial details
- NCT number
- NCT00717340
- Sponsor
- AVEO Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2011-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.